最后审核时间： 七月 2019
最近更新时间： 五月 2019
小结
定义
病史和查体
诊断性检查
治疗流程
贡献者
作者 查看所有
Consultant Rheumatologist
Auckland and Counties Manukau District Health Boards
Auckland
New Zealand
利益冲突披露
RS declares that he has no competing interests.Rheumatology Registrar
Nuffield Orthopaedic Centre
Oxford
UK
利益冲突披露
JR has attended symposia sponsored by Roche Ltd.Professor of Medicine
Rheumatology Department
Hopital Cochin
Paris
France
利益冲突披露
LG is an author of a number of references cited in this monograph.Professor of Rheumatology
NIHR Musculoskeletal Biomedical Research Unit
Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Science
University of Oxford
Oxford
UK
利益冲突披露
RL has attended symposia sponsored by GlaxoSmithKline, the manufacturer of Epivir (lamivudine), and has received sponsorship from Roche, Abbot Ltd, Schering Plough (the manufacturer of Remicade [infliximab]), and Wyeth (the manufacturer of Enbrel [etanercept]) to attend conferences. RL has received sponsorship from Sanofi Aventis (the manufacturer of Arava [leflunomide]) to support the costs of a meeting, and is on the Roche advisory board looking at treatment of vasculitis with B cell therapy. RL is an author of a number of references cited in this monograph.同行评议专家 查看所有
Professor and Vice Chair
Department of Medicine
University of Wisconsin Hospital
Madison
WI
利益冲突披露
AB declares that he has no competing interests.Consultant Rheumatologist
Ipswich Hospital
Ipswich
UK
利益冲突披露
RW has received fees for consulting from Roche Pharmaceuticals, manufacturer of rituximab. His department has received financial support from Wyeth Pharmaceuticals, manufacturer of etanercept, and from Schering-Plough, manufacturer of infliximab. RW is an author of a number of references cited in this monograph.Professor of Medicine
Department of Medicine
UMDNJ-Robert Wood Johnson Medical School
New Brunswick
NJ
利益冲突披露
ECE declares that she has no competing interests.
使用此内容应接受我们的免责声明。
